News Quantified

CASI – casi pharmaceuticals, inc. - ordinary shares (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Analysts Are Optimistic We'll See A Profit From CASI Pharmaceuticals, Inc. (NASDAQ:CASI) [Yahoo! Finance]

BioInvent International AB: Interim Report January-March 2024 [Yahoo! Finance]

CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS [Yahoo! Finance]

CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS

CASI Pharmaceuticals, Inc. (NASDAQ: CASI) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

1.1%

BEAT

3.6%

MISS

-7.5%

BEAT

Form 6-K CASI Pharmaceuticals, For: Apr 08

Form 6-K CASI Pharmaceuticals, For: Mar 28

Form 20-F CASI Pharmaceuticals, For: Dec 31

Form 144 CASI Pharmaceuticals, Filed by: Panacea Innovation Ltd

Form 6-K CASI Pharmaceuticals, For: Mar 13

Top News Gainers

3/16 Form 8-K CASI Pharmaceuticals, For: Mar 16 20.1%

3/24 Form SC 13D/A CASI Pharmaceuticals, Filed by: He Wei-Wu 16.1%

9/10 CASI Pharmaceuticals (CASI) Investor Presentation - Slideshow [Seeking Alpha] 6.8%

9/5 CASI Pharmaceuticals, Inc. to Host Key Opinion Leader Symposium on September 10, 2019 in New York City 6.1%

3/24 CASI Pharmaceuticals Inc (NASDAQ: CASI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.50 price target on the stock. 5.9%

3/19 Form 4 CASI Pharmaceuticals, For: Mar 17 Filed by: He Wei-Wu 4.2%

6/27 CASI Pharmaceuticals Inc (NASDAQ: CASI) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 3.3%

11/22 CASI Pharmaceuticals Inc (NASDAQ: CASI) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 3.3%

4/22 Form DEF 14A CASI Pharmaceuticals, For: Jun 16 2.8%

2/20 Form 8-K CASI Pharmaceuticals, For: Feb 19 2.4%

Top News Decliners

3/16 CASI Pharmaceuticals Announces Full Year 2019 Financial Results -8.9%

11/26 Form 8-K CASI Pharmaceuticals, For: Nov 20 -7.3%

5/10 Form NT 10-Q CASI Pharmaceuticals, For: Mar 31 -5.4%

4/7 CASI Pharmaceuticals To Present at 2020 Solebury Trout Virtual Investor Conference -5.2%

9/11 Form 8-K CASI Pharmaceuticals, For: Sep 10 -4.5%

9/13 CASI Pharmaceuticals Inc (NASDAQ: CASI) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -4.2%

2/19 Form SC 13G/A CASI Pharmaceuticals, Filed by: Wealth Strategy Holding Ltd -3.7%

9/19 CASI Pharmaceuticals Announces The Promotion Of Larry Zhang To President -3.6%

6/21 Form 8-K CASI Pharmaceuticals, For: Jun 20 -3.2%

10/4 CASI Pharmaceuticals Inc (NASDAQ: CASI) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -2.9%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day